Skip to main content
. 2020 Jun 19;319(2):H271–H281. doi: 10.1152/ajpheart.00177.2020

Table 2.

Baseline and maximal data

Non-Hispanic Black
Non-Hispanic White
Normotensive Prehypertensive Normotensive Prehypertensive
n 8 8 8 8
Baseline
 Control 15 ± 7 13 ± 9 17 ± 7 18 ± 11
 Lidocaine 13 ± 6 11 ± 4 12 ± 7 18 ± 9
l-NAME 8 ± 4 10 ± 5 10 ± 2 14 ± 5
 Lidocaine + l-NAME 9 ± 4 13 ± 10 12 ± 5 15 ± 8
Maximal CVC
 Control 2.27 ± 0.81 2.30 ± 0.61 2.16 ± 0.69 2.03 ± 0.55
 Lidocaine 2.51 ± 0.52 2.62 ± 0.70 2.67 ± 0.62 2.60 ± 0.34
l-NAME 2.30 ± 0.58 1.96 ± 0.55 2.25 ± 0.50 2.26 ± 0.51
 Lidocaine + l-NAME 2.52 ± 0.45 1.94 ± 0.56 2.02 ± 0.89 1.89 ± 0.58

Values are means ± SD. Baseline are maximal vasodilation (%CVCmax), and maximal values are cutaneous vascular conductance (CVC) (flux/mean arterial pressure). l-NAME, Nω-nitro-l-arginine methyl ester.